10.11.2016 12:03:11
|
DGAP-Stimmrechtsanteile: MeVis Medical Solutions AG
DGAP-PVR: MeVis Medical Solutions AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
3. Details of person subject to the notification obligation
Name: City and country of registered office: HANSAINVEST Hanseatische Hamburg Germany Investment-GmbH
4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.
5. Date on which threshold was crossed or reached
09 Nov 2016
6. Total positions
% of voting % of voting rights total of total number rights attached through instruments both in % of voting to shares (total (total of 7.b.1 + (7.a. + rights of of 7.a.) 7.b.2) 7.b.) issuer Result- 3.01 % 0 % 3.01 % 1820000 ing situat- ion Previo- 0 % 0 % 0 % / us notifi- cation
7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 21, 22 WpHG)
ISIN absolute in % direct (Sec. indirect (Sec. direct (Sec. indirect 21 WpHG) 22 WpHG) 21 WpHG) (Sec. 22 WpHG) DE000A0LBFE4 54,712 0 3.01 % 0 % Total 54,712 3.01 %
b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG
Type of Expiration or Exercise or Voting Voting instrument maturity date conversion rights rights in period absolute % % Total %
b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG
Type of Expiration Exercise or Cash or Voting Voting instrume- or maturity conversion physical rights rights nt date period settlement absolute in % % Total %
8. Information in relation to the person subject to the notification obligation
X Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
Name % of voting rights % of voting rights Total of both (if (if at least held 3% through instruments (if at least held 5% or more) at least held 5% or more) or more)
9. In case of proxy voting according to Sec. 22 para. 3 WpHG
Date of general meeting: Holding position after general meeting: % (equals voting rights)
10. Other explanatory remarks:
10.11.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
--------------------------------------------------------------------------- Language: English Company: MeVis Medical Solutions AG Caroline-Herschel-Str. 1 28359 Bremen Germany Internet: http://www.mevis.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------
MeVis Medical Solutions AG
10.11.2016 12:03
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Notification of Major Holdings
1. Details of issuer
MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
2. Reason for notification
X Acquisition/disposal of shares with voting rights
Acquisition/disposal of instruments
Change of breakdown of voting rights
Other reason:
3. Details of person subject to the notification obligation
Name: City and country of registered office: HANSAINVEST Hanseatische Hamburg Germany Investment-GmbH
4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.
5. Date on which threshold was crossed or reached
09 Nov 2016
6. Total positions
% of voting % of voting rights total of total number rights attached through instruments both in % of voting to shares (total (total of 7.b.1 + (7.a. + rights of of 7.a.) 7.b.2) 7.b.) issuer Result- 3.01 % 0 % 3.01 % 1820000 ing situat- ion Previo- 0 % 0 % 0 % / us notifi- cation
7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 21, 22 WpHG)
ISIN absolute in % direct (Sec. indirect (Sec. direct (Sec. indirect 21 WpHG) 22 WpHG) 21 WpHG) (Sec. 22 WpHG) DE000A0LBFE4 54,712 0 3.01 % 0 % Total 54,712 3.01 %
b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG
Type of Expiration or Exercise or Voting Voting instrument maturity date conversion rights rights in period absolute % % Total %
b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG
Type of Expiration Exercise or Cash or Voting Voting instrume- or maturity conversion physical rights rights nt date period settlement absolute in % % Total %
8. Information in relation to the person subject to the notification obligation
X Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
Name % of voting rights % of voting rights Total of both (if (if at least held 3% through instruments (if at least held 5% or more) at least held 5% or more) or more)
9. In case of proxy voting according to Sec. 22 para. 3 WpHG
Date of general meeting: Holding position after general meeting: % (equals voting rights)
10. Other explanatory remarks:
10.11.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
--------------------------------------------------------------------------- Language: English Company: MeVis Medical Solutions AG Caroline-Herschel-Str. 1 28359 Bremen Germany Internet: http://www.mevis.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!